Clarus Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,794
Closed -$238K 136
2019
Q4
$238K Sell
2,794
-586
-17% -$48.1K 0.16% 119
2019
Q3
$271K Buy
3,380
+107
+3% +$8.57K 0.2% 109
2019
Q2
$262K Buy
3,273
+2,648
+424% +$203K 0.19% 83
2019
Q1
$50K Buy
625
+5
+0.8% +$374 0.04% 289
2018
Q4
$45K Buy
620
+3
+0.5% +$212 0.07% 272
2018
Q3
$42K Sell
617
-614
-50% -$39.1K 0.03% 323
2018
Q2
$64K Buy
+1,231
New +$69.4K 0.05% 248

Other funds holding MRK

Clarus Wealth Advisors's MRK Position: Q1 2020 in Review

Clarus Wealth Advisors sold out of Merck (MRK) in Q1 2020, closing a stake of 2,794 shares — an estimated $238K sold.

Clarus Wealth Advisors first reported a position in MRK in Q2 2018 and held it in 7 quarters. The position peaked at $271K in Q3 2019. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Clarus Wealth Advisors reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
  • Clarus Wealth Advisors sold 2,794 Merck shares in Q1 2020, an estimated $238K.
  • Clarus Wealth Advisors first reported a position in Merck in Q2 2018 and held it in 7 quarters.
  • Clarus Wealth Advisors's Merck position peaked at $271K in Q3 2019.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Clarus Wealth Advisors's 13F filing for Q1 2020, filed 8 Apr 2020.